CPMI and IOSCO published a consultative report on the governance arrangements for critical data elements (CDEs) of the over-the-counter (OTC) derivatives. CDEs are elements other than the Unique Transaction Identifier (UTI) and the Unique Product Identifier (UPI). The document identifies key criteria, functions, and bodies for the governance arrangements for critical data. Consultation ends on September 27, 2018.
The consultative report discusses the key criteria for the CDE maintenance and governance, the different areas of CDE governance and governance functions, and a proposed allocation of the governance functions to different bodies—that is, the Maintenance Body, the International Governance Body, and Authorities. After assessing CDE against other OTC derivatives data elements (the UTI, the UPI, and the LEI), the document discusses governance arrangements for the execution of maintenance functions by a Maintenance Body and factors relevant for the identification of the International Governance Body. Finally, the consultative report briefly mentions the approach of CPMI and IOSCO to CDE implementation.
This consultative report complements the technical guidance on harmonization of UTI, the technical guidance on harmonization of UPI, and the technical guidance on harmonization of critical OTC derivatives data elements (other than UTI and UPI). This is a further step toward fulfilling the G20's commitment to report all OTC derivatives contracts to trade repositories, to improve transparency, mitigate systemic risk, and prevent market abuse. Aggregating the data reported across trade repositories will help ensure that authorities have a comprehensive overview of the OTC derivatives market and its activity.
Comment Due Date: September 27, 2018
Keywords: International, Securities, Banking, OTC Derivatives, Governance Arrangements, Critical Data Elements, Trade Repository, CPMI/IOSCO
Previous ArticleFCA Announces Creation of Global Financial Innovation Network
EU published Directive 2021/338, which amends the Markets in Financial Instruments Directive (MiFID) II and the Capital Requirements Directives (CRD 4 and 5) to facilitate recovery from the COVID-19 crisis.
The Standing Committee of the European Free Trade Association (EFTA) recommended that a systemic risk buffer level of 4.5% for domestic exposures can be considered appropriate for addressing the identified systemic risks to the stability of the financial system in Norway.
In a recent statement, PRA clarified its approach to the application of certain EU regulatory technical standards and EBA guidelines on standardized and internal ratings-based approaches to credit risk, following the end of the Brexit transition.
In a recently published letter addressed to the G20 finance ministers and central bank governors, the FSB Chair Randal K. Quarles has set out the key FSB priorities for 2021.
EU published, in the Official Journal of the European Union, a corrigendum to the revised Capital Requirements Regulation (CRR2 or Regulation 2019/876).
ESAs published a joint supervisory statement on the effective and consistent application and on national supervision of the regulation on sustainability-related disclosures in the financial services sector (SFDR).
EC published a public consultation on the review of crisis management and deposit insurance frameworks in EU.
HKMA announced that enhancements will be made to the Special 100% Loan Guarantee of the SME Financing Guarantee Scheme (SFGS) and the application period will be extended to December 31, 2021.
EBA launched consultations on the regulatory and implementing technical standards on cooperation and information exchange between competent authorities involved in prudential supervision of investment firms.
BoE issued a letter to the CEOs of eight major UK banks that are in scope of the first Resolvability Assessment Framework (RAF) reporting and disclosure cycle.